Literature DB >> 6825785

ABO system incompatibility: evaluation of risk of hyperbilirubinaemia at birth by multivariate discriminant analysis.

M Orzalesi, F Gloria-Bottini, P Lucarelli, N Lucarini, E Carapella, E Bottini.   

Abstract

A discriminant analysis was performed on a set of maternal and neonatal variables to predict at birth the serum bilirubin levels during the neonatal period in infants incompatible with their mothers in the ABO system. The results suggest that the rational and simultaneous utilization of clinical and laboratory parameters allows, a few hours after delivery, a useful classification of these infants in low or high risk for hyperbilirubinemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825785     DOI: 10.1007/bf01960645

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  6 in total

1.  Abortion: a hypothesis on the role of ABO blood groups and placental alkaline phosphatase.

Authors:  E Bottini
Journal:  Soc Biol       Date:  1975

2.  ABO system incompatibility: relationship between direct Coombs test positivity and neonatal jaundice.

Authors:  M Orzalesi; F Gloria; P Lucarelli; E Bottini
Journal:  Pediatrics       Date:  1973-02       Impact factor: 7.124

3.  Correlation of cord bilirubin levels with hyperbilirubinaemia in ABO incompatibility.

Authors:  H M Risemberg; E Mazzi; M G MacDonald; M Peralta; F Heldrich
Journal:  Arch Dis Child       Date:  1977-03       Impact factor: 3.791

4.  Interaction between placental alkaline phosphatase and ABO system polymorphisms during intrauterine life.

Authors:  E Bottini; P Lucarelli; P Pigram; R Palmarino; G F Spennati; M Orzalesi
Journal:  Am J Hum Genet       Date:  1972-09       Impact factor: 11.025

5.  Interaction between placental alkaline phosphatase and ABO system polymorphisms. Effects on the clinical manifestations of feto-maternal ABO incompatibility.

Authors:  E Bottini; P Lucarelli; M Orzalesi; R Palmarino; M Di Mino; F Gloria; L Terrenato; G F Spennati
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

6.  Further evidence for a racial difference in frequency of ABO hemolytic disease.

Authors:  H N Kirkman
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.